medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2017, Number 1

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2017; 33 (1)

Hematopoietic progenitor transplantation at the Institute of Hematology and Immnunology: past, present and future

Jaime FJC, Dorticós BE

Language: Spanish
References: 17
Page: 1-7
PDF size: 95.50 Kb.


ABSTRACT

In the year 2016, the 50th anniversary of the Institute of Hematology and Immunology was commemorated. In 1985, hematopoietic transplantation was initiated in our institution, and its development has followed the sequence of the universal history of this type of transplant. In this work we refer to the most important achievements in these years, and the introduction of new technologies such as the use of peripheral blood, the introduction of non-myeloablative transplantation and the of techniques of molecular chimerism. In addition, data from patients transplanted during this period are provided. It outlines the prospects for the development of the process in the coming years.


REFERENCES

  1. Dorticós E, González A, Hernández P. El trasplante de médula ósea en Cuba. Aportes del Instituto de Hematología e Inmunología. Rev Cubana Hematol Inmunol Hemoter. 1996;12(2):119-29.

  2. Thomas ED, Storb R. Technique for human bone marrow grafting. Blood 1970;36:507-15.

  3. Hernández P, Callejas J, Dorticós E, Reboredo M, Rodríguez E. Modelo de filtro metálico para médula ósea. Rev Cubana Hematol Inmunol Hemoter 1995;11:63-7.

  4. Dorticós Balea E, Jaime Fagundo JC, Pavón Morán V, Reboredo Domínguez M, Hernández Ramírez P. Actualización en trasplante de células progenitoras hematopoyéticas en pacientes pediátricos en los últimos 15 años. Rev Cubana Hematol Inmunol Hemoter. 2011:27(1)119-27.

  5. Stahl T, Rothe C, Böhme MU, Kohl A, Kröger N, Fehse B. Digital PCR Panel for Sensitive Hematopoietic Chimerism Quantification after Allogeneic Stem Cell Transplantation. Int J Mol Sci. 2016 Sep 9;17(9). pii: E1515. doi: 10.3390/ijms17091515.

  6. King AA, Bunin N, Sahdev I, Brochstein JA, Abraham A, Dioguardi J, et al. Non- Myeloablative Conditioning Targeting Host Immunosuppression Is Successful in Matched Sibling Donor Stem Cell Transplantation for Hemoglobinopathies in Children. Blood.2014;124(21):3873.

  7. Körbling M, Burke P, Braine H, Elfenbein G, Santos G, Kaizer H. Successful engraftment of blood derived normal hemopoietic stem cells in chronic myelogenous leukemia. Exp Hematol. 1981;9:684-90.

  8. Bell A, Figes A, Oscier D, Hamblin T. Peripheral blood stem cell autografting. Lancet. 1986;1(8488):1027.

  9. Pasquini MC, Zhu X. Current uses and outcomes of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2015. (Citado Diciembre 07, 2016). Available at: http://www.cibmtr.org/ referencecenter/slidesreports/summaryslides/Pages/index.aspx

  10. Gowda M, Ambardar S, Dighe N, Manjunath A, Shankaralingu C. Comparative Analyses of Low, Medium and High- Resolution HLA Typing Technologies for Human Populations. J Clin Cell Immunol. 2016;7:399. doi:10.4172/2155-9899.1000399.

  11. Martínez JC, Arrazola A. Importancia de la tipificación HLA en alta resolución para trasplante de células progenitoras hematopoyéticas. Rev Med Inst Mex Seguro Soc. 2006;44(Supl. 2):11-4

  12. Kanakry CG, Fuchs EJ, Luznik L. Modern approaches to HLA-haploidentical blood or marrow transplantation. Nat Rev Clin Oncol. 2016;13:10-24. doi: 10.1038/nrclinonc.2015.128.

  13. Kanda Y, Chiba S, Hirai H, Sakamaki H, Iseki T, Kodera Y, et al. Allogeneic hematopoietic stem cell transplantation from family members other than HLAidentical siblings over the last decade (1991-2000). Blood. 2003 Aug 15;102(4):1541-7.

  14. Luznik L, O'Donnell PV, Fuchs J. Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical BMT. Semin Oncol. 2012 Dec;39(6):683-93. doi: 10.1053/j.seminoncol.2012.09.005.

  15. Bashey A, Solomon SR. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor. Bone Marrow Transplant. 2014 Aug;49(8):999-1008.

  16. Luznik L, Fuchs EJ. High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation. Immunol Res. 2013 Jul;47(1-3):65-77.

  17. Jaime Fagundo JC, Romero González A, Anoceto Martínez A, Arencibia Núñez. Recuperación temprana de linfocitos como factor pronóstico en el trasplante hematopoyético. Rev Cubana Hematol Inmunol Hemoter. 2014;30(3):223-32




2020     |     www.medigraphic.com